Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF

Sanders-van Wijk Sandra; Masson Serge; Milani Valentina; Rickenbacher Peter; Gorini Marco; Tavazzi Luigi T.; Tobler Daniel; Rickli Hans; Latini Roberto; Brunner-La Roccaenen Hans-Peter

首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF

【24h】

Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF

机译：Galectin-3浓度与β受体阻滞剂和RAS阻滞剂对收缩性心力衰竭患者治疗作用的相互作用：TIME-CHF和GISSI-HF的衍生验证研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND: Galectin-3 predicts prognosis in heart failure (HF) and may help to select HF patients in need of intensified therapy.

机译：背景：Galectin-3可以预测心力衰竭（HF）的预后，并可能有助于选择需要加强治疗的HF患者。

著录项

来源
《Clinical Chemistry: Journal of the American Association for Clinical Chemists》 |2016年第4期|共12页
作者
Sanders-van Wijk Sandra; Masson Serge; Milani Valentina; Rickenbacher Peter; Gorini Marco; Tavazzi Luigi T.; Tobler Daniel; Rickli Hans; Latini Roberto; Brunner-La Roccaenen Hans-Peter;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类诊断学;
关键词

相似文献

外文文献
中文文献
专利

1. Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF [J] . Sanders-van Wijk Sandra, Masson Serge, Milani Valentina, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2016,第4期

机译：Galectin-3浓度与β受体阻滞剂和RAS阻滞剂对收缩性心力衰竭患者治疗作用的相互作用：TIME-CHF和GISSI-HF的衍生验证研究
2. Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF [J] . Daniel Tobler, Hans Rickli, Hans-Peter Brunner-La Roccaenen, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2016,第4期

机译：Galectin-3浓度与β受体阻滞剂和RAS阻滞剂对收缩性心力衰竭患者相互作用的交互作用：来自TIME-CHF和GISSI-HF的推导验证研究
3. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose?: Findings from the SHIFT (Systolic Heart failure treatment with the I f inhibitor ivabradine Trial) study [J] . SwedbergK., KomajdaM., B?hmM., Journal of the American College of Cardiology . 2012,第22期

机译：依伐布雷定对充血性心力衰竭患者心率降低结局的影响：β-受体阻滞剂剂量是否有影响？：SHIFT（使用If抑制剂依伐布雷定试验进行收缩性心力衰竭治疗）的研究结果
4. Rationale for Treatment of Heart Failure by Blockade of Ventricular Serotonin Receptors Appearing in Heart Failure [C] . E. Qvigstad -, T. Brattelid, I. Sjaasta International Society for Heart Research . 2005

机译：通过封锁心力衰竭出现的心室血清素受体治疗心力衰竭的理由
5. The effect of beta-blocker therapy, ACE inhibitor therapy, and digoxin therapy on the risk of hospitalization and resource utilization among patients with congestive heart failure enrolled in a managed care organization. [D] . Abarca, Jacob. 2001

机译：在管理性医疗机构中，充血性心力衰竭患者的β受体阻滞剂治疗，ACEI抑制剂治疗和地高辛治疗对住院风险和资源利用风险的影响。
6. Novel concept to guide systolic heart failure medication by repeated biomarker testing—results from TIME-CHF in context of predictive preventive and personalized medicine [O] . Nasser Davarzani, Sandra Sanders-van Wijk, Micha T. Maeder, 2018

机译：通过重复的生物标志物测试指导收缩性心力衰竭药物治疗的新概念-TIME-CHF在预测性预防性和个性化医学的背景下得出的结果
7. Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF [O] . Sanders-van Wijk, Sandra, Masson, Serge, Milani, Valentina, 2016

机译：Galectin-3浓度与β受体阻滞剂和RAS阻滞剂对收缩性心力衰竭患者治疗作用的相互作用：来自TIME-CHF和GISSI-HF的推导验证研究
8. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11; Heart Failure: Management of Patients with Left-Ventricular Systolic Dysfunction. Quick Reference Guide for Clinicians No. 11; Living with Heart Disease: Is It Heart Failure. Patient and Family Guide [R] . 1994

机译：心力衰竭：左心室收缩功能障碍患者的评估和护理。临床实践指南第11号;心力衰竭：左心室收缩功能障碍患者的治疗。临床医生快速参考指南第11号;与心脏病共存：是心衰吗？患者和家庭指南

Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF

摘要

著录项

相似文献

相关主题

期刊订阅